logo
  Join        Login             Stock Quote

Market Loses Track As Oil Prices Tumble, Oracle And Accenture Register Profits

 June 23, 2011 05:14 PM
 


A sharp decline in oil prices and discouraging economic data pushed the US market to a new low in the morning session before it recovered to close on a mixed note as Greece won the consent of the European Union and International Monetary Fund for a new five-year austerity plan.

The Dow Jones industrial average lost 0.49 percent or 59.52 points to close at 12,050.15, and the Standard & Poor's 500 index fell 0.28 percent or 3.61 points to end at 1,283.53. The Nasdaq Stock Market Inc. composite index added 0.66 percent or 17.56 points to finish the day at 2,686.75. Among other major indices, the New York Stock Exchange composite index slipped 0.59 percent or 47.76 points to end at 8,054.08. The American Stock Exchange composite index closed at 2,279.87, down 0.98 percent or 22.64.

[Related -What does Istanbul have to do with AAPL?]

Hot Stocks of the Day: ORCL, ACN, GOOG, BMY, AZN, VNV, CVC

Oracle Corp. (Nasdaq: ORCL) registered a 36 percent increase in its fiscal fourth-quarter net income to $3.2 billion, or 62 cents per share, up from $2.4 billion, or 46 cents a share a year earlier. During the quarter, the company's revenue rose 13 percent to $10.8 billion. Analysts had estimated earnings of 71 cents per share on revenue of $10.8 billion for the company. Shares gained 0.80 percent or 26 cents to close at $32.46.

Accenture Plc (NYSE: ACN) reported operating income of $949 million in its fiscal third-quarter, up 18 percent over its previous year. During the quarter, revenue rose 21 percent to $6.7 billion. Diluted earnings per share were 93 cents, an increase of 27 cents over the corresponding quarter. Shares gained 0.80 percent or 44 cents to close at $55.69.

[Related -Google Inc (GOOG) Q4 Earnings Preview: What To Watch?]

Google Inc. (Nasdaq: GOOG) is set to receive civil subpoenas from the Federal Trade Commission signaling the start of an anti-trust probe against the Internet-search giant. Shares were down 1.39 percent or $6.79 to end at $480.22.

The new diabetes pill dapagliflozin from Bristol-Myers Squibb Co. (NYSE: BMY) and Astrazeneca Plc (NYSE: AZN) is expected to face increased scrutiny from the US Food and Drug Administration and doctors. Shares of Bristol-Myers added 5.73 percent or $1.59 to close at $29.33, while shares of AZN were down 0.61 percent or 30 cents to end at $48.89.

Viacom, Inc.


Next Page >>12
iOnTheMarket Premium
Advertisement

Advertisement


Comments Closed


rss feed

Latest Stories

article imageChipotle Mexican Grill, Inc. (CMG) Q2 Earnings Preview: Will Higher Traffic Offset Higher Costs the Key

Chipotle Mexican Grill, Inc. (NYSE:CMG) will host a conference call to discuss second quarter 2014 read on...

article imageNetflix, Inc. (NFLX) Q2 Earnings Preview: The Ruby Month for a Reason

Netflix, Inc. (NASDAQ:NFLX) will post its second-quarter 2014 financial results and business outlook on its read on...

article imageLadenburg Thalmann Financial Services (NYSEMKT:LTS): Heavy, Durable Insider Buying

Ahh, but any worries over price levels didn’t stop multiple insiders at Ladenburg Thalmann Financial read on...

article imageInternational Business Machines Corp. (IBM) Q2 Earnings Preview: Small Beat and Pop

International Business Machines Corp. (NYSE:IBM) will host a conference call Wednesday, Jul. 16, 2014 at read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.